↑ 薬物リストへ　← 戻る

Sustained release growth hormone    (DrugBank: Growth hormone)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
78下垂体前葉機能低下症1

78. 下垂体前葉機能低下症　［臨床試験数：462，薬物数：346（DrugBank：45），標的遺伝子数：41，標的パスウェイ数：80］
Searched query = "Hypopituitarism", "Anterior pituitary hypothyroidism", "Syndrome of abnormal secretion of gonadotropin", "Hyposecretion of gonadotropins", "Adrenocorticotropic hormone deficiency", "ACTH deficiency", "Thyroid-stimulating hormone deficiency", "TSH deficiency", "Growth hormone deficiency", "GH deficiency", "GHD", "CGHD", "AGHD", "Prolactin deficiency", "PRL deficiency"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 462 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1EUCTR2006-002278-24-IT
(EUCTR)		05/04/200716/12/2008A phase III, open-label, uncontrolled, multicentre, rollover study to assess safety and efficacy of LB03002 administered weekly in adults with growth hormone deficiency. - BPLG-005-ROA phase III, open-label, uncontrolled, multicentre, rollover study to assess safety and efficacy of LB03002 administered weekly in adults with growth hormone deficiency. - BPLG-005-RO Growth hormone deficiency
MedDRA version: 9.1;Level: HLT;Classification code 10002701;Term: Anterior pituitary hypofunction		Product Name: LB03002
INN or Proposed INN: sustained release growth hormone 		BIOPARTNERS GMBHNULLNot RecruitingFemale: yes
Male: yes		150Phase 3United Kingdom;Czech Republic;Germany;France;Spain;Italy;Austria;Sweden